Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod

Author(s):

Virginia Palomares Cabeza, Laura Y.L. Kummer, Luuk Wieske, Ruth R. Hagen, Mariel Duurland, Veronique A.L. Konijn, Koos P.J. Van Dam, Eileen W. Stalman, Carolien E. Van De Sandt, Laura Boekel, Niels J.M. Verstegen, Maurice Steenhuis, Theo Rispens, Sander W. Tas, Gertjan Wolbink, Joep Killestein, Taco W. Kuijpers, S. Marieke Van Ham, Filip Eftimov, Anja Ten Brinke, Zoé L.E. Van Kempen

Details:

Neurology: Neuroimmunology and NeuroInflammation, Volume 9, Issue 4, 2022-07-06, Article number e1178

Article Link: Click here

Affiliations:

• Universiteit van Amsterdam
• Amsterdam UMC - Vrije Universiteit Amsterdam
• Department of Microbiology & Immunology
• Swammerdam Institute for Life Sciences
• Sanquin Research
• Amsterdam Rheumatology and Immunology Center